Nancy Lane

May 8, 2024 | medscape.com | Nancy Lane

VIENNA — Data do not back the use of diacerein or resveratrol for managing the pain of knee osteoarthritis (OA), according to the results of two well-performed, multicenter, double-blind, randomized controlled clinical trials. During the News in Therapies session at the World Congress on Osteoarthritis (OARSI) 2024 Annual Meeting, the null findings of the DICKENS study and ARTHROL trial were presented alongside a reappraisal of the possible role of botulinum toxin.

May 7, 2024 | medscape.com | Nancy Lane

VIENNA — Encouraging primary or secondary analyses of trial data for the use of several novel injectables and gene therapy for knee osteoarthritis (OA) were reported at the World Congress on Osteoarthritis (OARSI) 2024 Annual Meeting. Of all the approaches discussed during the News in Therapies session at OARSI 2024, the most intriguing was the use of the placental extract PTP-001 (MOTYS, Bioventus), Session Chair Nancy E.

Apr 19, 2024 | healio.com | Nancy Lane |Shenaz Bagha

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Reflecting on my decision to forge a career path in medicine and rheumatology, there were a series of experiences that strongly influenced me.

Feb 13, 2024 | healio.com | Nancy Lane |Shenaz Bagha

You've successfully added Rheumatology: Practice Management to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Reflecting on my decision to forge a career path in medicine and rheumatology, there were a series of experiences that strongly influenced me.

Jan 29, 2024 | healio.com | Shenaz Bagha |Nancy Lane

You've successfully added Rheumatology: Pain Management to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:PF614-MAR helps prevent overdoses by “shutting down” active drug release if too much has been consumed, the manufacturer said.